OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study
Richeek Pradhan, Sally Lu, Hui Yin, et al.
BMJ (2022), pp. e071380-e071380
Open Access | Times Cited: 60
Richeek Pradhan, Sally Lu, Hui Yin, et al.
BMJ (2022), pp. e071380-e071380
Open Access | Times Cited: 60
Showing 1-25 of 60 citing articles:
COPD and multimorbidity: recognising and addressing a syndemic occurrence
Leonardo M. Fabbri, Bartolomé R. Celli, Àlvar Agustí, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 11, pp. 1020-1034
Open Access | Times Cited: 87
Leonardo M. Fabbri, Bartolomé R. Celli, Àlvar Agustí, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 11, pp. 1020-1034
Open Access | Times Cited: 87
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Yehuda Handelsman, John E. Anderson, George L. Bakris, et al.
Metabolism (2024) Vol. 159, pp. 155931-155931
Open Access | Times Cited: 23
Yehuda Handelsman, John E. Anderson, George L. Bakris, et al.
Metabolism (2024) Vol. 159, pp. 155931-155931
Open Access | Times Cited: 23
Mapping the effectiveness and risks of GLP-1 receptor agonists
Yan Xie, Taeyoung Choi, Ziyad Al‐Aly
Nature Medicine (2025)
Closed Access | Times Cited: 19
Yan Xie, Taeyoung Choi, Ziyad Al‐Aly
Nature Medicine (2025)
Closed Access | Times Cited: 19
Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary Disease Exacerbations in Patients With Type 2 Diabetes
Avik Ray, Julie M. Paik, Deborah J. Wexler, et al.
JAMA Internal Medicine (2025)
Closed Access | Times Cited: 5
Avik Ray, Julie M. Paik, Deborah J. Wexler, et al.
JAMA Internal Medicine (2025)
Closed Access | Times Cited: 5
Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study
Han Eol Jeong, Sohee Park, Yunha Noh, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Han Eol Jeong, Sohee Park, Yunha Noh, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Cardiovascular disease and risk in COPD: a state of the art review
Ricardo Polman, John R. Hurst, Ömer Uysal, et al.
Expert Review of Cardiovascular Therapy (2024) Vol. 22, Iss. 4-5, pp. 177-191
Open Access | Times Cited: 16
Ricardo Polman, John R. Hurst, Ömer Uysal, et al.
Expert Review of Cardiovascular Therapy (2024) Vol. 22, Iss. 4-5, pp. 177-191
Open Access | Times Cited: 16
Use of SGLT2 Inhibitors vs GLP-1 RAs and Anemia in Patients With Diabetes and CKD
Jia-Chian Hu, Shih‐Chieh Shao, Daniel Hsiang-Te Tsai, et al.
JAMA Network Open (2024) Vol. 7, Iss. 3, pp. e240946-e240946
Open Access | Times Cited: 13
Jia-Chian Hu, Shih‐Chieh Shao, Daniel Hsiang-Te Tsai, et al.
JAMA Network Open (2024) Vol. 7, Iss. 3, pp. e240946-e240946
Open Access | Times Cited: 13
Extrapulmonary Comorbidities Associated with Chronic Obstructive Pulmonary Disease: A Review
Yurong Xiang, X. Luo
International Journal of COPD (2024) Vol. Volume 19, pp. 567-578
Open Access | Times Cited: 12
Yurong Xiang, X. Luo
International Journal of COPD (2024) Vol. Volume 19, pp. 567-578
Open Access | Times Cited: 12
Association of GLP-1 Receptor Agonists with Chronic Obstructive Pulmonary Disease Exacerbations among Patients with Type 2 Diabetes
Dinah Foer, Zachary H. Strasser, Jing Cui, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 208, Iss. 10, pp. 1088-1100
Closed Access | Times Cited: 22
Dinah Foer, Zachary H. Strasser, Jing Cui, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 208, Iss. 10, pp. 1088-1100
Closed Access | Times Cited: 22
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease
Wenwen Wang, Aihua Mei, Hang Qian, et al.
International Journal of COPD (2023) Vol. Volume 18, pp. 129-137
Open Access | Times Cited: 19
Wenwen Wang, Aihua Mei, Hang Qian, et al.
International Journal of COPD (2023) Vol. Volume 18, pp. 129-137
Open Access | Times Cited: 19
The relationship between the use of GLP-1 receptor agonists and the incidence of respiratory illness: a meta-analysis of randomized controlled trials
Meixin Yu, Ruxin Wang, Ling Pei, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Meixin Yu, Ruxin Wang, Ling Pei, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Heterogeneous treatment effects of sodium‐glucose cotransporter 2 inhibitors on risk of dementia in people with type 2 diabetes: A population‐based cohort study
Huilin Tang, William T. Donahoo, Mikael Svensson, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5528-5539
Open Access | Times Cited: 8
Huilin Tang, William T. Donahoo, Mikael Svensson, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5528-5539
Open Access | Times Cited: 8
Lower risks of cirrhosis and hepatocellular carcinoma with GLP‐1RAs in type 2 diabetes: A nationwide cohort study using target trial emulation framework
Chun‐Ting Yang, Wenyu Yao, Chen‐Yi Yang, et al.
Journal of Internal Medicine (2023) Vol. 295, Iss. 3, pp. 357-368
Closed Access | Times Cited: 14
Chun‐Ting Yang, Wenyu Yao, Chen‐Yi Yang, et al.
Journal of Internal Medicine (2023) Vol. 295, Iss. 3, pp. 357-368
Closed Access | Times Cited: 14
The role of Sodium-Glucose Transporter-2 Inhibitors (SGLT-2i) in preventing chronic obstructive disease exacerbation in patients with diabetes and COPD: An electronic health database analysis
Sushan Gupta, Avani Mohta, Alexa Lauinger, et al.
Heart & Lung (2024) Vol. 68, pp. 191-194
Closed Access | Times Cited: 5
Sushan Gupta, Avani Mohta, Alexa Lauinger, et al.
Heart & Lung (2024) Vol. 68, pp. 191-194
Closed Access | Times Cited: 5
Liraglutide pretreatment attenuates sepsis-induced acute lung injury
Brandon Baer, Nathan D. Putz, Kyle Riedmann, et al.
AJP Lung Cellular and Molecular Physiology (2023) Vol. 325, Iss. 3, pp. L368-L384
Open Access | Times Cited: 13
Brandon Baer, Nathan D. Putz, Kyle Riedmann, et al.
AJP Lung Cellular and Molecular Physiology (2023) Vol. 325, Iss. 3, pp. L368-L384
Open Access | Times Cited: 13
Associations of diabetes, prediabetes and diabetes duration with the risk of chronic obstructive pulmonary disease: A prospective UK Biobank study
Jian Su, Mengyao Li, Xinglin Wan, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 9, pp. 2575-2585
Open Access | Times Cited: 11
Jian Su, Mengyao Li, Xinglin Wan, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 9, pp. 2575-2585
Open Access | Times Cited: 11
Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort Study
Samantha B. Shapiro, Hui Yin, Oriana Hoi Yun Yu, et al.
Drug Safety (2024) Vol. 47, Iss. 8, pp. 759-769
Closed Access | Times Cited: 4
Samantha B. Shapiro, Hui Yin, Oriana Hoi Yun Yu, et al.
Drug Safety (2024) Vol. 47, Iss. 8, pp. 759-769
Closed Access | Times Cited: 4
Association of Novel Antihyperglycemic Drugs Versus Metformin With a Decrease in Asthma Exacerbations
Yuya Kimura, Taisuke Jo, Norihiko Inoue, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 8, pp. 2035-2044
Open Access | Times Cited: 4
Yuya Kimura, Taisuke Jo, Norihiko Inoue, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 8, pp. 2035-2044
Open Access | Times Cited: 4
Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD
Fu‐Shun Yen, Chih‐Cheng Hsu, James Cheng‐Chung Wei, et al.
Thorax (2024), pp. thorax-221040
Closed Access | Times Cited: 4
Fu‐Shun Yen, Chih‐Cheng Hsu, James Cheng‐Chung Wei, et al.
Thorax (2024), pp. thorax-221040
Closed Access | Times Cited: 4
Glucagon-like peptide-1 receptor agonism and end-organ protection
Samuel J. Daniels, Cecilia Karlsson, Patrick Schrauwen, et al.
Trends in Endocrinology and Metabolism (2025)
Open Access
Samuel J. Daniels, Cecilia Karlsson, Patrick Schrauwen, et al.
Trends in Endocrinology and Metabolism (2025)
Open Access
Expanding the Use of SGLT2 Inhibitors in T2D Patients Across Clinical Settings
Alessandro Cuttone, Vittorio Cannavò, Rana Abdullah, et al.
Cells (2025) Vol. 14, Iss. 9, pp. 668-668
Open Access
Alessandro Cuttone, Vittorio Cannavò, Rana Abdullah, et al.
Cells (2025) Vol. 14, Iss. 9, pp. 668-668
Open Access
EPOC y riesgo cardiovascular
Carlos Santiago Díaz, Francisco J. Medrano, Nuria Muñoz‐Rivas, et al.
Clínica e Investigación en Arteriosclerosis (2025), pp. 500757-500757
Closed Access
Carlos Santiago Díaz, Francisco J. Medrano, Nuria Muñoz‐Rivas, et al.
Clínica e Investigación en Arteriosclerosis (2025), pp. 500757-500757
Closed Access
Update zu COPD und kardiovaskulären Ereignissen
Maximilian Leitner, A. Blum, Robert Bals
DMW - Deutsche Medizinische Wochenschrift (2025) Vol. 150, Iss. 06, pp. 298-302
Closed Access
Maximilian Leitner, A. Blum, Robert Bals
DMW - Deutsche Medizinische Wochenschrift (2025) Vol. 150, Iss. 06, pp. 298-302
Closed Access
Effect of newer glucose-lowering medications on chronic obstructive pulmonary disease exacerbations among individuals with type 2 diabetes
Paschalis Karakasis, Dimitrios Patoulias, Nikolaos Fragakis, et al.
European Journal of Internal Medicine (2025)
Closed Access
Paschalis Karakasis, Dimitrios Patoulias, Nikolaos Fragakis, et al.
European Journal of Internal Medicine (2025)
Closed Access
Comparison of SGLT2 and DPP4 inhibitors on clinical outcomes in COPD patients with diabetes: A nationwide cohort study
Ting‐Chia Chang, Yingkuan Liang, Chih-Cheng Lai, et al.
Diabetes Research and Clinical Practice (2025), pp. 112122-112122
Closed Access
Ting‐Chia Chang, Yingkuan Liang, Chih-Cheng Lai, et al.
Diabetes Research and Clinical Practice (2025), pp. 112122-112122
Closed Access
